Colorectal cancer: Fra kirurgisk kurasjon til multimodale behandlingsstrategier – prediksjon av prognose og terapirespons
- Prosjektnummer
- 2008050
- Ansvarlig person
- Kjersti Flatmark
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients.
Tumour Biol 2012 Feb;33(1):73-83. Epub 2011 okt 18
PMID: 22006279 - Inngår i doktorgradsavhandlingen
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer.
BMC Cancer 2012;12():505. Epub 2012 nov 2
PMID: 23121918 - Inngår i doktorgradsavhandlingen
B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.
Int J Cancer 2012 Dec;131(11):2528-36. Epub 2012 apr 24
PMID: 22473715
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Br J Cancer 2012 Aug;107(4):667-74. Epub 2012 jul 10
PMID: 22782346
Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma.
Radiat Oncol 2012;7():165. Epub 2012 sep 27
PMID: 23017053
Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancer.
PLoS One 2012;7(11):e50806. Epub 2012 nov 30
PMID: 23226389
Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.
Angiogenesis 2011 Dec;14(4):481-9. Epub 2011 aug 11
PMID: 21833622
Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma.
Amino Acids 2011 Oct;41(4):875-84. Epub 2010 feb 27
PMID: 20191297
Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome.
Colorectal Dis 2011 May;13(5):506-11.
PMID: 20236148
Disseminated tumour cells as a prognostic biomarker in colorectal cancer.
Br J Cancer 2011 Apr;104(9):1434-9. Epub 2011 mar 29
PMID: 21448171
Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy.
Radiat Oncol 2011;6():33. Epub 2011 apr 8
PMID: 21473790
TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins.
Tumour Biol 2011 Feb;32(1):1-12. Epub 2010 jul 24
PMID: 20652782
Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
Eur J Cancer 2010 Nov;46(16):2919-25. Epub 2010 aug 16
PMID: 20719498
MicroRNAs as biomarkers in colorectal cancer.
Am J Pathol 2010 Oct;177(4):1592-9. Epub 2010 sep 9
PMID: 20829435 - Inngår i doktorgradsavhandlingen
Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study.
BMC Cancer 2010;10():469. Epub 2010 sep 1
PMID: 20809961
Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.
Int J Radiat Oncol Biol Phys 2010 Oct;78(2):555-62. Epub 2010 aug 2
PMID: 20675069
Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models.
Hum Pathol 2010 Aug;41(8):1109-19. Epub 2010 mar 24
PMID: 20338618
Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
Int J Radiat Oncol Biol Phys 2009 Jun;74(2):546-52.
PMID: 19427556
MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy.
Radiother Oncol 2009 Nov;93(2):279-84. Epub 2009 okt 1
PMID: 19800704
Deep sequencing the microRNA transcriptome in colorectal cancer
Submitted PLOSOne 2013
Prognostic biomarkers in colorectal cancer with emphasis on microRNA
- Disputert:
- desember 2012
- Hovedveileder:
- Kjersti Flatmark
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport